| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.325 | 16.080 | 18.394 | 16.093 | 18.459 | 8.224 | 12.744 | 15.742 | 13.006 | 6.359 |
| Total Income - EUR | 16.325 | 16.080 | 18.394 | 16.093 | 18.459 | 8.224 | 12.744 | 15.742 | 13.006 | 6.359 |
| Total Expenses - EUR | 15.434 | 14.427 | 16.753 | 13.750 | 15.221 | 7.950 | 11.426 | 13.637 | 11.635 | 6.114 |
| Gross Profit/Loss - EUR | 892 | 1.653 | 1.641 | 2.344 | 3.238 | 274 | 1.318 | 2.104 | 1.371 | 244 |
| Net Profit/Loss - EUR | 402 | 1.172 | 1.089 | 1.861 | 2.684 | 118 | 1.062 | 1.703 | 1.185 | 210 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cipralina Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 5.366 | 6.598 | 8.478 | 8.943 | 8.613 | 5.858 | 3.627 | 6.250 | 6.012 | 5.794 |
| Inventories | 5.364 | 6.591 | 8.174 | 8.932 | 8.610 | 5.856 | 3.544 | 6.245 | 4.900 | 3.852 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
| Cash | 2 | 7 | 304 | 11 | 3 | 2 | 83 | 5 | 1.112 | 1.930 |
| Shareholders Funds | -7.254 | -6.007 | -4.817 | -2.868 | -128 | -8 | 1.055 | 2.761 | 3.937 | 4.125 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.620 | 12.606 | 13.295 | 11.811 | 8.740 | 5.866 | 2.572 | 3.489 | 2.075 | 1.669 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4782
|
|||||||||
Comments - Cipralina Srl